Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian D Gillmore

Showing results (1-10 of 331) with videos related to

Pageof 34
Sort By:
The American Journal of Medicine|January 26, 2022
When to Suspect and How to Approach a Diagnosis of AmyloidosisSteven Law, Julian D Gillmore
The New England Journal of Medicine|January 17, 2024
Patisiran in Patients with Transthyretin Cardiac Amyloidosis. ReplyMathew S Maurer, Julian D Gillmore
The New England Journal of Medicine|April 30, 2015
V122I transthyretin variant in elderly black AmericansJulian D Gillmore, Philip N Hawkins
British Journal of Hospital Medicine (London, England : 2005)|March 12, 2010
Renal amyloidosisHelen J Lachmann, Julian D Gillmore
Nature Clinical Practice. Nephrology|August 26, 2006
Drug Insight: emerging therapies for amyloidosisJulian D Gillmore, Philip N Hawkins
Nature Reviews. Nephrology|August 28, 2013
Pathophysiology and treatment of systemic amyloidosisJulian D Gillmore, Philip N Hawkins
Circulation. Cardiovascular Imaging|September 8, 2022
Letter by Porcari et al Regarding Article, "Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation"Aldostefano Porcari, Marianna Fontana, Julian D Gillmore
JACC. Basic to Translational Science|October 24, 2024
Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients: Future Clinical ImplicationsMarianna Fontana, Julian D Gillmore, Guglielmo Verona
Heart International|July 17, 2023
Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with CardiomyopathyAdam Ioannou, Marianna Fontana, Julian D Gillmore
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 16, 2023
RNA Targeting and Gene Editing Strategies for Transthyretin AmyloidosisAdam Ioannou, Marianna Fontana, Julian D Gillmore
Pageof 34

Showing results (1-10 of 331) with videos related to

Sort By:
Pageof 34
The American Journal of Medicine|January 26, 2022
When to Suspect and How to Approach a Diagnosis of AmyloidosisSteven Law, Julian D Gillmore
The New England Journal of Medicine|January 17, 2024
Patisiran in Patients with Transthyretin Cardiac Amyloidosis. ReplyMathew S Maurer, Julian D Gillmore
The New England Journal of Medicine|April 30, 2015
V122I transthyretin variant in elderly black AmericansJulian D Gillmore, Philip N Hawkins
British Journal of Hospital Medicine (London, England : 2005)|March 12, 2010
Renal amyloidosisHelen J Lachmann, Julian D Gillmore
Nature Clinical Practice. Nephrology|August 26, 2006
Drug Insight: emerging therapies for amyloidosisJulian D Gillmore, Philip N Hawkins
Nature Reviews. Nephrology|August 28, 2013
Pathophysiology and treatment of systemic amyloidosisJulian D Gillmore, Philip N Hawkins
Circulation. Cardiovascular Imaging|September 8, 2022
Letter by Porcari et al Regarding Article, "Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation"Aldostefano Porcari, Marianna Fontana, Julian D Gillmore
JACC. Basic to Translational Science|October 24, 2024
Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients: Future Clinical ImplicationsMarianna Fontana, Julian D Gillmore, Guglielmo Verona
Heart International|July 17, 2023
Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with CardiomyopathyAdam Ioannou, Marianna Fontana, Julian D Gillmore
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 16, 2023
RNA Targeting and Gene Editing Strategies for Transthyretin AmyloidosisAdam Ioannou, Marianna Fontana, Julian D Gillmore
Pageof 34